These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11302799)

  • 41. Anti-HIV natural product (+)-calanolide A is active against both drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis.
    Xu ZQ; Barrow WW; Suling WJ; Westbrook L; Barrow E; Lin YM; Flavin MT
    Bioorg Med Chem; 2004 Mar; 12(5):1199-207. PubMed ID: 14980631
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a Phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjects.
    Sarashina A; Sesoko S; Nakashima M; Hayashi N; Taniguchi A; Horie Y; Graefe-Mody EU; Woerle HJ; Dugi KA
    Clin Ther; 2010 Jun; 32(6):1188-204. PubMed ID: 20637971
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Safety, tolerability, and pharmacokinetics of sumatriptan in healthy subjects following ascending single intranasal doses and multiple intranasal doses.
    Moore KH; Hussey EK; Shaw S; Fuseau E; Duquesnoy C; Pakes GE
    Cephalalgia; 1997 Jun; 17(4):541-50. PubMed ID: 9209776
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics and tolerability of etamicastat following single and repeated administration in elderly versus young healthy male subjects: an open-label, single-center, parallel-group study.
    Nunes T; Rocha JF; Vaz-da-Silva M; Falcão A; Almeida L; Soares-da-Silva P
    Clin Ther; 2011 Jun; 33(6):776-91. PubMed ID: 21704242
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Determination of 10-chloromethyl-11-demethyl-12-oxo-calanolide A in rat plasma using liquid chromatography-tandem mass spectrometry and its application to pharmacokinetics.
    Sheng L; Zhang Q; Liu Z; Liu X; Wang B; Chen H; Li Y
    Biomed Chromatogr; 2014 Dec; 28(12):1589-91. PubMed ID: 24760543
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetic and Safety Profile of the Novel HIV Nonnucleoside Reverse Transcriptase Inhibitor MK-8507 in Adults without HIV.
    Ankrom W; Jackson Rudd D; Schaeffer A; Panebianco D; Friedman EJ; Tomek C; Stoch SA; Iwamoto M
    Antimicrob Agents Chemother; 2021 Nov; 65(12):e0093521. PubMed ID: 34516246
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Selective inhibition of HIV-1 reverse transcriptase-associated ribonuclease H activity by hydroxylated tropolones.
    Budihas SR; Gorshkova I; Gaidamakov S; Wamiru A; Bona MK; Parniak MA; Crouch RJ; McMahon JB; Beutler JA; Le Grice SF
    Nucleic Acids Res; 2005; 33(4):1249-56. PubMed ID: 15741178
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Steady-state pharmacokinetics of once-daily cyclobenzaprine extended release: a randomized, double-blind, 2-period crossover study in healthy volunteers.
    Darwish M; Hellriegel ET
    Clin Ther; 2011 Jun; 33(6):746-53. PubMed ID: 21704239
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chemical library and structure-activity relationships of 11-demethyl-12-oxo calanolide A analogues as anti-HIV-1 agents.
    Ma T; Liu L; Xue H; Li L; Han C; Wang L; Chen Z; Liu G
    J Med Chem; 2008 Mar; 51(5):1432-46. PubMed ID: 18284187
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics and short-term safety of 873140, a novel CCR5 antagonist, in healthy adult subjects.
    Adkison KK; Shachoy-Clark A; Fang L; Lou Y; O'Mara K; Berrey MM; Piscitelli SC
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2802-6. PubMed ID: 15980352
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetic properties of mirabegron, a β3-adrenoceptor agonist: results from two phase I, randomized, multiple-dose studies in healthy young and elderly men and women.
    Krauwinkel W; van Dijk J; Schaddelee M; Eltink C; Meijer J; Strabach G; van Marle S; Kerbusch V; van Gelderen M
    Clin Ther; 2012 Oct; 34(10):2144-60. PubMed ID: 23063375
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety and pharmacokinetics of 5-chloro-2',3'-dideoxy-3'-fluorouridine (935U83) following oral administration of escalating single doses in human immunodeficiency virus-infected adults.
    Riddler SA; Wang LH; Bartlett JA; Savina PM; Packard MV; McMahon DK; Blum MR; Dunn JA; Elkins MM; Mellors JW
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2842-7. PubMed ID: 9124852
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phase I safety and pharmacokinetic trials of 1263W94, a novel oral anti-human cytomegalovirus agent, in healthy and human immunodeficiency virus-infected subjects.
    Wang LH; Peck RW; Yin Y; Allanson J; Wiggs R; Wire MB
    Antimicrob Agents Chemother; 2003 Apr; 47(4):1334-42. PubMed ID: 12654667
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Naturally Occurring Calanolides: Occurrence, Biosynthesis, and Pharmacological Properties Including Therapeutic Potential.
    Nahar L; Talukdar AD; Nath D; Nath S; Mehan A; Ismail FMD; Sarker SD
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33126458
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vivo anti-HIV activity of (+)-calanolide A in the hollow fiber mouse model.
    Xu ZQ; Hollingshead MG; Borgel S; Elder C; Khilevich A; Flavin MT
    Bioorg Med Chem Lett; 1999 Jan; 9(2):133-8. PubMed ID: 10021914
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The bioavailability of the novel nonnucleoside reverse transcriptase inhibitor GW420867X is unaffected by food in healthy male volunteers.
    Cass LM; Moore KH; Dallow NS; Jones AE; Sisson JR; Prince WT
    J Clin Pharmacol; 2001 May; 41(5):528-35. PubMed ID: 11361049
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multiple-dose escalation study of the safety, pharmacokinetics, and biologic activity of oral AMD070, a selective CXCR4 receptor inhibitor, in human subjects.
    Stone ND; Dunaway SB; Flexner C; Tierney C; Calandra GB; Becker S; Cao YJ; Wiggins IP; Conley J; MacFarland RT; Park JG; Lalama C; Snyder S; Kallungal B; Klingman KL; Hendrix CW
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2351-8. PubMed ID: 17452489
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of candidate genes related to calanolide biosynthesis by transcriptome sequencing of Calophyllum brasiliense (Calophyllaceae).
    Gómez-Robledo HB; Cruz-Sosa F; Bernabé-Antonio A; Guerrero-Analco A; Olivares-Romero JL; Alonso-Sánchez A; Villafán E; Ibarra-Laclette E
    BMC Plant Biol; 2016 Aug; 16(1):177. PubMed ID: 27527830
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetics of nevirapine: initial single-rising-dose study in humans.
    Cheeseman SH; Hattox SE; McLaughlin MM; Koup RA; Andrews C; Bova CA; Pav JW; Roy T; Sullivan JL; Keirns JJ
    Antimicrob Agents Chemother; 1993 Feb; 37(2):178-82. PubMed ID: 8452345
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fluoride Pharmacokinetics in Urine and Plasma Following Multiple Doses of MK-8507, an Investigational, Oral, Once-Weekly Nonnucleoside Reverse Transcriptase Inhibitor.
    Gillespie G; Jackson Rudd D; Zhang S; Schaeffer A; Tomek C; Larson P; Stoch SA; Iwamoto M
    J Clin Pharmacol; 2022 Feb; 62(2):199-205. PubMed ID: 34435371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.